%0 Journal Article %A Artur Badyda %A Andrzej Chciałowski %A Piotr Dąbrowiecki %A Adam Stańczyk %A Piotr Czechowski %A Anna Gayer %A Dominika Mucha %A Łukasz Adamkiewicz %T Coal and wood burning products as a risk factor of respiratory and cardiovascular diseases – preliminary results of household PM2.5 emissions on health risk %D 2017 %R 10.1183/1393003.congress-2017.OA1777 %J European Respiratory Journal %P OA1777 %V 50 %N suppl 61 %X Background: 69.3% of individual households in Poland produces thermal energy from coal burning (in 13.7% there are also fireplaces for wood and biomass). They are responsible for 55.8% of fine particulate matter (PM2.5) emission. As mentioned by Badyda et al. Adv Exp Med Biol 2016;944:1-9 in Polish cities PM2.5 is responsible for 10-33% of cardiopulmonary mortality.Material and Methods: 500 people from a small city in the agglomeration of Warsaw were surveyed in an ongoing study on the exposure to PM2.5 from individual households. A questionnaire was conducted and selected 100 people are undergoing medical examination (spirometry test, induced sputum composition, FeNO, CO in the exhaled air, skin prick tests, total and specific IgE, hemodynamics, vascular endothelial function). Statistical analysis was completed (e.g. ANOVA, GRM, PCA).Results: PM2.5 standards in the city are not met (in 2015 were >32 μg/m3). Though only 21% of the investigated inhabitants suppose that air quality is low or very low. Significant fraction of never-smokers (56.4% of the whole examined group) demonstrate symptoms typical for people exposed to air pollutants (PM), like conjunctivitis (21.5% of the non-smokers), rhinitis (34.2%), larynx inflammation (18.1%), frequent respiratory infections (16.1%) but also breathlessness/tightness and pain behind the breastbone (14.8%). Pulmonary symptoms significantly more often occur in people with FEV1<114%. Asthma was diagnosed in 8.1%, coronary heart disease in 4.7% and COPD in 2% of the group.Conclusion: Exposure to PM2.5 in never smokers may increase the prevalence of respiratory and cardiovascular diseases. %U